Not applicableStudy completedNCT05069545
What this trial is testing
A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice
Who this might be right for
Diabetes Mellitus, Type 1
Novo Nordisk A/S 411